These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3370625)

  • 1. Implications for the formation of abasic sites following modification of polydeoxycytidylic acid by acrolein in vitro.
    Smith RA; Sysel IA; Tibbels TS; Cohen SM
    Cancer Lett; 1988 May; 40(1):103-9. PubMed ID: 3370625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 1,N6-propanodeoxyadenosine in acrolein-modified polydeoxyadenylic acid and DNA by 32P postlabeling.
    Smith RA; Williamson DS; Cerny RL; Cohen SM
    Cancer Res; 1990 May; 50(10):3005-12. PubMed ID: 2334905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 3,N4-propanodeoxycytidine 5'-monophosphate formed by the reaction of acrolein with deoxycytidine 5'-monophosphate.
    Smith RA; Williamson DS; Cohen SM
    Chem Res Toxicol; 1989; 2(4):267-71. PubMed ID: 2519782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA.
    Guichard Y; Nair J; Barbin A; Bartsch H
    IARC Sci Publ; 1993; (124):263-9. PubMed ID: 8225494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabeling of bile components: bulky adduct-like behavior in polyethyleneimine-cellulose thin layer chromatography.
    Vulimiri SV; Smith CV; Randerath E; Randerath K
    Carcinogenesis; 1994 Sep; 15(9):2061-4. PubMed ID: 7923604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered fidelity of a nucleic acid modifying enzyme, T4 polynucleotide kinase, by safrole-induced DNA damage.
    Randerath K; Gupta KP; van Golen KL
    Carcinogenesis; 1993 Aug; 14(8):1523-9. PubMed ID: 8102596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct determination of uracil in [32P,uracil-3H]poly(dA.dT) and bisulfite-treated phage PM2 DNA.
    Green DA; Deutsch WA
    Anal Biochem; 1984 Nov; 142(2):497-503. PubMed ID: 6528982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
    Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
    Gupta RC; Earley K
    Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution TLC mapping and characterization of 32P-postlabeled monophosphate 7,12-dimethylbenz[a]anthracene-DNA adducts.
    Yang PF; Randerath K
    Carcinogenesis; 1990 Jan; 11(1):159-64. PubMed ID: 2104782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-labeling test for DNA damage.
    Randerath K; Reddy MV; Gupta RC
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6126-9. PubMed ID: 7031643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32P-postlabelling approaches for the detection of 8-oxo-2'-deoxyguanosine-3'-monophosphate in DNA.
    Podmore K; Farmer PB; Herbert KE; Jones GD; Martin EA
    Mutat Res; 1997 Aug; 378(1-2):139-49. PubMed ID: 9288892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of two ultrasensitive methods for measuring 1,N6-etheno-2'-deoxyadenosine and 3,N4-etheno-2'-deoxycytidine in cellular DNA.
    Misra RR; Chiang SY; Swenberg JA
    Carcinogenesis; 1994 Aug; 15(8):1647-52. PubMed ID: 8055645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32P-postlabelling analysis of small aromatic and of bulky non-aromatic DNA adducts.
    Reddy MV
    IARC Sci Publ; 1993; (124):25-34. PubMed ID: 8225492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.